Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARTEMIS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction

NCT06118281 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT06118281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06118281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARTEMIS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 25, 2024
Completion date
January 29, 2027
Enrollment
10,000 (estimated)
Sites
836

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction (ami), cardiovascular risk